Pericarditis: Auto-Inflammation in Recurrent Disease
NCT04996108 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 119
Last updated 2021-08-17
Summary
Pericarditis is swelling of the sac that surrounds the heart, the pericardium, causing chest pain. For most patients, the condition improves with simple anti-inflammatory medications like colchicine and ibuprofen. However, in 20-30% of patients the condition comes back. Diagnosis of recurrent pericarditis is frequently missed or delayed, and many patients require prolonged courses of corticosteroids to control their disease. Together these factors damage the quality of life of patients with recurrent pericarditis. Currently there is limited understanding of why pericarditis comes back in some patients, and how best to treat it when it does.
PAIReD (Pericarditis: Auto-Inflammation in Recurrent Disease) is an observational research study funded by the British Heart Foundation that will investigate the role inflammation plays in recurrent pericarditis. Patients with recurrent pericarditis and other auto-inflammatory diseases will be recruited from the specialist fever clinic at the Royal Free Hospital, where they will be asked to donate blood up to six times over a three year period. Healthy participants will be recruited at the Royal Free Hospital or Guy's Hospital. Relatives of participants with recurrent pericarditis will be recruited at the Royal Free Hospital. They latter two groups will attend one appointment where blood or saliva samples will be taken. A subset of participants will also provide fingerstick blood samples and questionnaires from home, for up to one year.
Clinical data will be collected prospectively and by retrospective case note review. Blood from participants will be analysed to look at how the immune cells of patients with recurrent pericarditis function during the course of their disease, and to look for genetic changes in patients with recurrent pericarditis that might contribute to their condition. Together this knowledge has to potential to help clinicians diagnose and monitor patients with recurrent pericarditis more accurately, and researchers to design more effective treatments.
Conditions
- Idiopathic Recurrent Pericarditis
Sponsors & Collaborators
-
Guy's and St Thomas' NHS Foundation Trust
collaborator OTHER -
Royal Free Hospital NHS Foundation Trust
collaborator OTHER - lead OTHER
Principal Investigators
-
Claire J Peet, BMBCh MRCP · Clinical research fellow
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-07-29
- Primary Completion
- 2024-06-13
- Completion
- 2024-06-13
Countries
- United Kingdom
Study Locations
More Related Trials
-
Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode)
NCT00128414 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)
NCT06591260 ·Status: RECRUITING
-
Colchicine in HFpEF
NCT04857931 ·Status: TERMINATED ·Phase: PHASE2
-
Colchicine Versus Placebo in Acute Myocarditis Patients
NCT05855746 ·Status: RECRUITING ·Phase: PHASE3
-
REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients
NCT04687358 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Safety and Efficacy of RPH-104 in Preventing Recurrences in Patients With Idiopathic Recurrent Pericarditis
NCT05673902 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.
NCT00235079 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis
NCT05107934 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)
NCT05494788 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Inflammation in Heart Failure
NCT05330013 ·Status: WITHDRAWN ·Phase: PHASE2
-
Monitoring Drug-induced Myocarditis (CardiTOX)
NCT03855982 ·Status: COMPLETED
-
A Pilot Study of KPL-914 in Recurrent Pericarditis
NCT03980522 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis
NCT07010159 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The COLchicine HEART Failure PRESERVED Trial (COLHEART-PRESERVED)
NCT06081049 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Idiopathic Recurrent Pericarditis
NCT04692766 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
NCT06158698 ·Status: RECRUITING ·Phase: PHASE3
-
Intravenous Allopurinol in Heart Failure
NCT00181155 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Short-term Prednisone Therapy on C-reactive Protein in Patients With Acute Heart Failure
NCT05916586 ·Status: COMPLETED ·Phase: NA
-
Single-Ascending Dose Study of JK07 in Subjects With HFpEF
NCT05322616 ·Status: WITHDRAWN ·Phase: PHASE1
-
Role of Colchicine as Anti-Inflammatory Therapy in HFpEF
NCT06837623 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy
NCT05961202 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF)
NCT02354573 ·Status: COMPLETED ·Phase: NA
-
Interleukin-1 Blockade in HF With Preserved EF
NCT02173548 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Arachidonate 5-Lipoxygenase Enzyme in Affecting the Risk for Coronary Heart Disease
NCT00379808 ·Status: COMPLETED ·Phase: NA
-
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
NCT05636176 ·Status: RECRUITING ·Phase: PHASE3